Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Design and Baseline Characteristics: ProgStar Report No. 1.

Strauss RW, Ho A, Muñoz B, Cideciyan AV, Sahel JA, Sunness JS, Birch DG, Bernstein PS, Michaelides M, Traboulsi EI, Zrenner E, Sadda S, Ervin AM, West S, Scholl HP; Progression of Stargardt Disease Study Group.

Ophthalmology. 2016 Apr;123(4):817-28. doi: 10.1016/j.ophtha.2015.12.009. Epub 2016 Jan 16.

PMID:
26786511
2.

Macular Sensitivity Measured With Microperimetry in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 7.

Schönbach EM, Wolfson Y, Strauss RW, Ibrahim MA, Kong X, Muñoz B, Birch DG, Cideciyan AV, Hahn GA, Nittala M, Sunness JS, Sadda SR, West SK, Scholl HPN; ProgStar Study Group.

JAMA Ophthalmol. 2017 Jul 1;135(7):696-703. doi: 10.1001/jamaophthalmol.2017.1162.

PMID:
28542693
3.

Incidence of Atrophic Lesions in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 5.

Strauss RW, Muñoz B, Ho A, Jha A, Michaelides M, Mohand-Said S, Cideciyan AV, Birch D, Hariri AH, Nittala MG, Sadda S, Scholl HPN; ProgStar Study Group.

JAMA Ophthalmol. 2017 Jul 1;135(7):687-695. doi: 10.1001/jamaophthalmol.2017.1121.

4.

Progression of Stargardt Disease as Determined by Fundus Autofluorescence in the Retrospective Progression of Stargardt Disease Study (ProgStar Report No. 9).

Strauss RW, Muñoz B, Ho A, Jha A, Michaelides M, Cideciyan AV, Audo I, Birch DG, Hariri AH, Nittala MG, Sadda S, West S, Scholl HPN; ProgStar Study Group.

JAMA Ophthalmol. 2017 Nov 1;135(11):1232-1241. doi: 10.1001/jamaophthalmol.2017.4152.

5.

The Progression of the Stargardt Disease Type 4 (ProgStar-4) Study: Design and Baseline Characteristics (ProgStar-4 Report No. 1).

Strauss RW, Muñoz B, Ahmed MI, Bittencourt M, Schönbach EM, Michaelides M, Birch D, Zrenner E, Ervin AM, Charbel Issa P, Kong J, Wolfson Y, Shah M, Bagheri S, West S, Scholl HPN; for the ProgStar-4 Study Group.

Ophthalmic Res. 2018;60(3):185-194. doi: 10.1159/000491791. Epub 2018 Aug 15.

PMID:
30110705
6.

Visual Acuity Change over 12 Months in the Prospective Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: ProgStar Report Number 6.

Kong X, Strauss RW, Cideciyan AV, Michaelides M, Sahel JA, Munoz B, Ahmed M, Ervin AM, West SK, Cheetham JK, Scholl HPN; ProgStar Study Group.

Ophthalmology. 2017 Nov;124(11):1640-1651. doi: 10.1016/j.ophtha.2017.04.026. Epub 2017 May 23.

PMID:
28549516
7.

Disruption in Bruch membrane in patients with Stargardt disease.

Park SP, Chang S, Allikmets R, Smith RT, Burke TR, Gregory-Roberts E, Tsang SH.

Ophthalmic Genet. 2012 Mar;33(1):49-52. doi: 10.3109/13816810.2011.628358. Epub 2011 Nov 7.

8.

Asymmetric Inter-Eye Progression in Stargardt Disease.

Lambertus S, Bax NM, Groenewoud JM, Cremers FP, van der Wilt GJ, Klevering BJ, Theelen T, Hoyng CB.

Invest Ophthalmol Vis Sci. 2016 Dec 1;57(15):6824-6830. doi: 10.1167/iovs.16-20963.

PMID:
28002570
9.

Natural History of Geographic Atrophy Progression Secondary to Age-Related Macular Degeneration (Geographic Atrophy Progression Study).

Schmitz-Valckenberg S, Sahel JA, Danis R, Fleckenstein M, Jaffe GJ, Wolf S, Pruente C, Holz FG.

Ophthalmology. 2016 Feb;123(2):361-8. doi: 10.1016/j.ophtha.2015.09.036. Epub 2015 Nov 3.

PMID:
26545317
10.

Early-onset stargardt disease: phenotypic and genotypic characteristics.

Lambertus S, van Huet RA, Bax NM, Hoefsloot LH, Cremers FP, Boon CJ, Klevering BJ, Hoyng CB.

Ophthalmology. 2015 Feb;122(2):335-44. doi: 10.1016/j.ophtha.2014.08.032. Epub 2014 Oct 17.

PMID:
25444351
11.

En Face Spectral-Domain Optical Coherence Tomography for the Monitoring of Lesion Area Progression in Stargardt Disease.

Melillo P, Testa F, Rossi S, Di Iorio V, Orrico A, Auricchio A, Simonelli F.

Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT247-52. doi: 10.1167/iovs.15-18751.

12.

Multimodal analysis of the Preferred Retinal Location and the Transition Zone in patients with Stargardt Disease.

Verdina T, Greenstein VC, Sodi A, Tsang SH, Burke TR, Passerini I, Allikmets R, Virgili G, Cavallini GM, Rizzo S.

Graefes Arch Clin Exp Ophthalmol. 2017 Jul;255(7):1307-1317. doi: 10.1007/s00417-017-3637-6. Epub 2017 Apr 2.

13.

Clinical and genetic characteristics of late-onset Stargardt's disease.

Westeneng-van Haaften SC, Boon CJ, Cremers FP, Hoefsloot LH, den Hollander AI, Hoyng CB.

Ophthalmology. 2012 Jun;119(6):1199-210. doi: 10.1016/j.ophtha.2012.01.005. Epub 2012 Mar 24.

PMID:
22449572
14.

A longitudinal comparison of spectral-domain optical coherence tomography and fundus autofluorescence in geographic atrophy.

Simader C, Sayegh RG, Montuoro A, Azhary M, Koth AL, Baratsits M, Sacu S, Prünte C, Kreil DP, Schmidt-Erfurth U.

Am J Ophthalmol. 2014 Sep;158(3):557-66.e1. doi: 10.1016/j.ajo.2014.05.026. Epub 2014 May 28.

PMID:
24879944
15.

Microperimetry Features of Geographic Atrophy Identified With En Face Optical Coherence Tomography.

Pilotto E, Convento E, Guidolin F, Abalsamo CK, Longhin E, Parrozzani R, Midena E.

JAMA Ophthalmol. 2016 Aug 1;134(8):873-9. doi: 10.1001/jamaophthalmol.2016.1535.

PMID:
27253760
16.
17.

Microperimetry, fundus autofluorescence, and retinal layer changes in progressing geographic atrophy.

Pilotto E, Benetti E, Convento E, Guidolin F, Longhin E, Parrozzani R, Midena E.

Can J Ophthalmol. 2013 Oct;48(5):386-93. doi: 10.1016/j.jcjo.2013.03.022.

PMID:
24093185
18.

A systematic comparison of spectral-domain optical coherence tomography and fundus autofluorescence in patients with geographic atrophy.

Sayegh RG, Simader C, Scheschy U, Montuoro A, Kiss C, Sacu S, Kreil DP, Prünte C, Schmidt-Erfurth U.

Ophthalmology. 2011 Sep;118(9):1844-51. doi: 10.1016/j.ophtha.2011.01.043. Epub 2011 Apr 15.

PMID:
21496928
19.

Morpho-functional correlation of fundus autofluorescence in Stargardt disease.

Parodi MB, Iacono P, Triolo G, La Spina C, Zucchiatti I, Cicinelli MV, Borrelli E, Manitto MP, Martina E, Bandello F.

Br J Ophthalmol. 2015 Oct;99(10):1354-9. doi: 10.1136/bjophthalmol-2014-306237. Epub 2015 Apr 2.

PMID:
25837607
20.

Fundus autofluorescence and microperimetry in progressing geographic atrophy secondary to age-related macular degeneration.

Pilotto E, Guidolin F, Convento E, Spedicato L, Vujosevic S, Cavarzeran F, Midena E.

Br J Ophthalmol. 2013 May;97(5):622-6. doi: 10.1136/bjophthalmol-2012-302633. Epub 2013 Feb 14.

PMID:
23410728

Supplemental Content

Support Center